Found: 40
Select item for more details and to access through your institution.
Ustekinumab v terapii idiopatických střevních zánětů.
- Published in:
- Remedia, 2024, v. 34, n. 3, p. 226
- By:
- Publication type:
- Article
Léčba střevních zánětů ve 21. století - individualizovaná terapie a telemedicína.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2021, v. 67, n. 4, p. 201
- By:
- Publication type:
- Article
Terapie peptického vředu.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2018, v. 64, n. 6, p. 595
- By:
- Publication type:
- Article
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, v. 12, p. 1, doi. 10.3389/fcimb.2022.1064537
- By:
- Publication type:
- Article
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 175, doi. 10.1111/apt.17751
- By:
- Publication type:
- Article
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort.
- Published in:
- European Journal of Pediatrics, 2024, v. 183, n. 10, p. 4243, doi. 10.1007/s00431-024-05683-4
- By:
- Publication type:
- Article
Biologická léčba IBD v roce 2011.
- Published in:
- Journal of Czech Physicians / Časopis Lékařů Českých, 2011, v. 150, n. 11, p. 637
- By:
- Publication type:
- Article
What is the origin of ulcerative colitis? Still more questions than answers.
- Published in:
- Postgraduate Medical Journal, 2006, v. 82, n. 972, p. 620, doi. 10.1136/pmj.2006.047035
- By:
- Publication type:
- Article
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Infliximab Biosimilar (Remsima<sup>TM</sup>) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 91, doi. 10.1159/000453343
- By:
- Publication type:
- Article
Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer.
- Published in:
- Digestive Diseases, 2010, v. 28, n. 4/5, p. 619, doi. 10.1159/000320276
- By:
- Publication type:
- Article
Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab.
- Published in:
- International Journal of Colorectal Disease, 2024, v. 39, n. 1, p. 1, doi. 10.1007/s00384-024-04727-3
- By:
- Publication type:
- Article
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2753, doi. 10.3390/jcm10132753
- By:
- Publication type:
- Article
Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2013, v. 27, n. 17, p. 1983, doi. 10.1002/rcm.6660
- By:
- Publication type:
- Article
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.
- Published in:
- Wiener Klinische Wochenschrift, 2007, v. 119, n. 17/18, p. 519, doi. 10.1007/s00508-007-0841-0
- By:
- Publication type:
- Article
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases.
- Published in:
- Intestinal Research, 2020, v. 18, n. 1, p. 34, doi. 10.5217/ir.2019.09147
- By:
- Publication type:
- Article
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 4, p. 1, doi. 10.1093/crocol/otad040
- By:
- Publication type:
- Article
Terapie těžke formy ulcerozni kolitidy.
- Published in:
- Medicina po Promoci, 2019, v. 20, n. 4, p. 328
- By:
- Publication type:
- Article
Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences.
- Published in:
- Dermatologic Therapy, 2014, v. 27, n. 3, p. 131, doi. 10.1111/dth.12083
- By:
- Publication type:
- Article
Association of IL23R p.381Gln and ATG16L1 p.197Ala with Crohn disease in the Czech population.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD.
- Published in:
- Journal of Immunology Research, 2023, p. 1, doi. 10.1155/2023/1535484
- By:
- Publication type:
- Article
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3188, doi. 10.3390/cells10113188
- By:
- Publication type:
- Article
Update on the Role of Rifaximin in Digestive Diseases.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, n. 1, p. 92, doi. 10.15403/jgld-4871
- By:
- Publication type:
- Article
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277576
- By:
- Publication type:
- Article
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A novel postgraduate endoscopic course using a large animal model of secondary Crohn's disease stricture.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases.
- Published in:
- Autoimmune Diseases (2090-0422), 2011, p. 1, doi. 10.4061/2011/945861
- By:
- Publication type:
- Article
Etiologie a patogeneze idiopatických střevních zánĕtů.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2014, v. 60, n. 7/8, p. 640
- By:
- Publication type:
- Article
Safety of Ustekinumab and Vedolizumab During Pregnancy—Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 12, p. 1808, doi. 10.1093/ecco-jcc/jjac086
- By:
- Publication type:
- Article
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 9, p. 1347, doi. 10.1093/ecco-jcc/jjac048
- By:
- Publication type:
- Article
Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 8, p. 1066, doi. 10.1093/ecco-jcc/jjaa027
- By:
- Publication type:
- Article
Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 7, p. 915, doi. 10.1093/ecco-jcc/jjaa001
- By:
- Publication type:
- Article
Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 5, p. 555, doi. 10.1093/ecco-jcc/jjy196
- By:
- Publication type:
- Article
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 11, p. 1294, doi. 10.1093/ecco-jcc/jjw103
- By:
- Publication type:
- Article
Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231174290
- By:
- Publication type:
- Article
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211032790
- By:
- Publication type:
- Article
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211006678
- By:
- Publication type:
- Article
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211032790
- By:
- Publication type:
- Article
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211006678
- By:
- Publication type:
- Article
The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease.
- Published in:
- BMC Medical Genetics, 2010, v. 11, p. 91, doi. 10.1186/1471-2350-11-91
- By:
- Publication type:
- Article